CD43
CD43, also known as sialophorin, is a glycoprotein that is predominantly expressed on the surface of various immune cells, including T cells, B cells, macrophages, and granulocytes. This protein plays a crucial role in the modulation of cell adhesion and immune response mechanisms.
Structure[edit]
CD43 is characterized by a large, heavily glycosylated extracellular domain, a transmembrane region, and a short cytoplasmic tail. The extensive glycosylation of the extracellular domain, which consists mostly of sialic acid residues, is critical for its function and interaction with other cellular components.
Function[edit]
The primary function of CD43 is to regulate cell-cell interactions within the immune system. It acts as an anti-adhesion molecule, meaning it generally inhibits the binding of cells to one another, facilitating the free movement of immune cells through the bloodstream and into tissues. This anti-adhesive property is crucial during the immune response, particularly in the migration of T cells to sites of infection or inflammation.
CD43 also transmits intracellular signals that can influence cell activation, proliferation, and differentiation. The cytoplasmic tail of CD43 interacts with various signaling molecules and plays a role in the activation pathways of T cells and other immune cells.
Clinical Significance[edit]
Alterations in the expression or function of CD43 have been implicated in several diseases. In cancer, CD43 expression can be altered in leukemia cells, affecting the behavior and survival of these cells. Additionally, because of its role in immune cell trafficking, CD43 has been studied in the context of autoimmune diseases, where improper immune cell activation and migration are common features.
Research[edit]
Ongoing research is focused on understanding the detailed mechanisms by which CD43 regulates immune responses and its potential as a therapeutic target in diseases involving the immune system. Studies are also exploring the role of CD43 in tumor progression and metastasis, given its function in cell movement and interaction.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
